Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action
Canadian Journal of Gastroenterology and Hepatology - Egypt
doi 10.1155/2016/6260271
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Hindawi Limited